New Research In
Physical Sciences
Social Sciences
Featured Portals
Articles by Topic
Biological Sciences
Featured Portals
Articles by Topic
- Agricultural Sciences
- Anthropology
- Applied Biological Sciences
- Biochemistry
- Biophysics and Computational Biology
- Cell Biology
- Developmental Biology
- Ecology
- Environmental Sciences
- Evolution
- Genetics
- Immunology and Inflammation
- Medical Sciences
- Microbiology
- Neuroscience
- Pharmacology
- Physiology
- Plant Biology
- Population Biology
- Psychological and Cognitive Sciences
- Sustainability Science
- Systems Biology
Adjuvant effect of the novel TLR1/TLR2 agonist Diprovocim synergizes with anti–PD-L1 to eliminate melanoma in mice
Edited by Dennis A. Carson, University of California, San Diego, La Jolla, CA, and approved July 2, 2018 (received for review June 28, 2018)

Online Impact
Article Information
- Published in issue September 11, 2018.
- Published first August 27, 2018.
Author Information
- Ying Wanga,
- Lijing Sua,
- Matthew D. Morinb,
- Brian T. Jonesb,
- Yuto Mifuneb,
- Hexin Shia,
- Kuan-wen Wanga,
- Xiaoming Zhana,
- Aijie Liua,
- Jianhui Wanga,
- Xiaohong Lia,
- Miao Tanga,
- Sara Ludwiga,
- Sara Hildebranda,
- Kejin Zhouc,d,
- Daniel J. Siegwartc,d,
- Eva Marie Y. Morescoa,
- Hong Zhanga,
- Dale L. Bogerb, and
- Bruce Beutlera,1
- aCenter for the Genetics of Host Defense, University of Texas Southwestern Medical Center, Dallas, TX 75390;
- bDepartment of Chemistry, The Scripps Research Institute, La Jolla, CA 92037;
- cSimmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390;
- dDepartment of Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX 75390
Edited by Dennis A. Carson, University of California, San Diego, La Jolla, CA, and approved July 2, 2018 (received for review June 28, 2018)
Footnotes
- ↵1To whom correspondence should be addressed. Email: bruce.beutler{at}utsouthwestern.edu.
Author contributions: Y.W. and B.B. designed research; Y.W., L.S., H.S., K.-w.W., X.Z., A.L., J.W., X.L., M.T., S.L., S.H., K.Z., D.J.S., and H.Z. performed research; M.D.M., B.T.J., Y.M., and D.L.B. contributed new reagents/analytic tools; Y.W. and B.B. analyzed data; and Y.W., E.M.Y.M., and B.B. wrote the paper.
Conflict of interest statement: B.B. and D.L.B. have financial interests in Tollbridge Therapeutics, LLC, which has licensed the patent for Diprovocim.
This article is a PNAS Direct Submission.
This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.1073/pnas.1809232115/-/DCSupplemental.
Cited By...
This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.
- Matthew D. Morin, Ying Wang, Brian T. Jones, Yuto Mifune, Lijing Su, Hexin Shi, Eva Marie Y. Moresco, Hong Zhang, Bruce Beutler, Dale L. BogerJournal of the American Chemical Society 2018 140 43
- Zhipeng Chen, Xiaohong Cen, Junjie Yang, Xiaoshan Tang, Kai Cui, Kui ChengChemical Communications 2018 54 81
Article usage
Citation Manager Formats
Sign up for Article Alerts
Jump to section
You May Also be Interested in
More Articles of This Classification
Related Content
Cited by...
- No citing articles found.